Files
Download Full Text (383 KB)
Disciplines
Nursing | Pharmacy and Pharmaceutical Sciences | Pulmonology
Description
Pulmonary arterial hypertension (PAH) is a rare, incurable disease that causes vasoconstriction of the pulmonary vasculature
Therapy goals include improving hemodynamics as well as alleviating symptoms
Therapies range from injectable to inhaled to oral to parenteral
PAH treatment teams often transition between the various forms of therapies to reach therapy goals but also to improve patient’s quality of life
The use of a supportive, multidisciplinary team approach, including physicians, nurse practitioners (NP), pharmacists, and nurses during these therapy transition phases is beneficial to achieve success and improve patient care
Publication Date
10-2024
Recommended Citation
Brewer J, Saeed T, Dalal B. Multidisciplinary approach to pulmonary arterial hypertension therapy transition: a patient case report. Presented at: American College of Chest Physicians (CHEST) Annual Meeting; 2024 Oct 6-9; Boston, MA.
Comments
American College of Chest Physicians (CHEST) Annual Meeting, October 6-9, 2024, Boston, MA.